Back to search

Article

Liquid Biopsy in Cholestatic Liver Disease Using Hepatocyte-Specific Methylation Markers

2021-02-19

Abstract excerpt

<h4>Background: </h4> Quantification of circulating organ-specific cell-free DNA (cfDNA) provides a sensitive measure of ongoing cell death that could benefit evaluation of the cholestatic liver diseases primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), which lack reliable non-invasive biomarkers. Our goal in this pilot study was to determine whether liver-specific cfDNA levels are increa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d00249bf-c7b8-556b-bdb9-3c7ecf374ce4
DOI
10.21203/rs.3.rs-209005/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Liquid Biopsy in Cholestatic Liver Disease Using Hepatocyte-Specific Methylation MarkersDOI 10.21203/rs.3.rs-209005/v1
Select a neighboring publication to make it the new centre.